Importantly, inhibitor kappa B kinase beta/nuclear factor-kappa B (IKKβ/NF-κB) signaling is involved in protection of MYDGF on non-alcoholic fatty liver disease (NAFLD). The gene discussed is IKBKB; the disease is metabolic dysfunction-associated steatotic liver disease.